GlassScriptPhysician profile
John A Stancher
NPI 1780761841
$3,968.80
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,777 · 2020: $1,041 · 2021: $1,092 · 2022: $46.16 · 2023: $13.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,074.04 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $483.35 | 2019-2021 | |
| Janssen Biotech, INC. | $461.70 | 2019-2022 | |
| Pfizer INC. | $421.62 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $374.95 | 2019-2021 | |
| Braintree Laboratories, INC. | $218.72 | 2019 | |
| Daiichi Sankyo INC. | $194.80 | 2019-2021 | |
| Gilead Sciences, INC. | $155.99 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $62.91 | 2020-2021 | |
| Ucb, INC. | $53.05 | 2019-2020 | |
| Allergan, INC. | $47.90 | 2020 | |
| Merck Sharp & Dohme LLC | $42.96 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $41.20 | 2019-2020 | |
| Amgen INC. | $40.07 | 2021 | |
| Pharmacosmos Therapeutics INC. | $38.17 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $35.18 | 2020 | |
| Celgene Corporation | $27.29 | 2021-2023 | Zeposia |
| Alnylam Pharmaceuticals INC. | $26.30 | 2021 | |
| Cook Medical LLC | $24.99 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $24.60 | 2021 | |
| Ethicon US, LLC | $24.43 | 2020 | |
| Romark Laboratories, Lc | $20.16 | 2019-2020 | |
| Evoke Pharma, INC. | $17.77 | 2020 | |
| Boston Scientific Corporation | $16.93 | 2019 | |
| Ambu INC. | $16.56 | 2020 | |
| Ferring Pharmaceuticals INC. | $11.69 | 2019 | |
| Endo Pharmaceuticals INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stancher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.